North America Colorectal Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

No. of Pages: 148    |    Report Code: BMIRE00028834    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Colorectal Cancer Diagnostics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Colorectal Cancer Diagnostics Market – by Modality

1.3.2        North America Colorectal Cancer Diagnostics Market – by End User

1.3.3        North America Colorectal Cancer Diagnostics Market – by Country

2.           North America Colorectal Cancer Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Colorectal Cancer Diagnostics Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert’s Opinion

5.           North America Colorectal Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Colorectal Cancer

5.1.2        Launches of New Products

5.2         Key Restraints

5.2.1        Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)

5.3         Opportunities

5.3.1        Growing Awareness of Colorectal Cancer

5.4         Future Trends

5.4.1        Artificial Intelligence in Colonoscopy

5.5         Impact Analysis

6.           Colorectal Cancer Diagnostics Market – North America Analysis

6.1         North America Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis

6.2         North America Colorectal Cancer Diagnostics Market, By Geography - Forecast and Analysis

7.           North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality

7.1         Overview

7.2         North America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)

7.3         Stool Based Tests

7.3.1        Overview

7.3.2        Stool Based Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Faecal Immunochemical Test (FIT)

7.3.3.1          Overview

7.3.3.2          Faecal Immunochemical Test (FIT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Guaiac-based Faecal Occult Blood Test (gFOBT)

7.3.4.1          Overview

7.3.4.2          Guaiac-based Faecal Occult Blood Test (gFOBT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Stool DNA Test

7.3.5.1          Overview

7.3.5.2          Stool DNA Test: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Imaging Tests

7.4.1        Overview

7.4.2        Imaging Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Colonoscopy

7.4.3.1          Overview

7.4.3.2          Colonoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        CT Colonography

7.4.4.1          Overview

7.4.4.2          CT Colonography: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Flexible Sigmoidoscopy

7.4.5.1          Overview

7.4.5.2          Flexible Sigmoidoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6        Capsule Endoscopy

7.4.6.1          Overview

7.4.6.2          Capsule Endoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.7        Others

7.4.7.1          Overview

7.4.7.2          Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User

8.1         Overview

8.2         North America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Cancer Research Institutes

8.5.1        Overview

8.5.2        Cancer Research Institutes: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Country Analysis

9.1         Overview

9.1.1.1          US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1          Overview

9.1.1.1.2          US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3          US: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.1.3.1        US: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.1.3.2        US: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.1.4          US: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.2          Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1          Overview

9.1.1.2.2          Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3          Canada: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.2.3.1        Canada: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.2.3.2        Canada: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.2.4          Canada: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.3          Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1          Overview

9.1.1.3.2          Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3          Mexico: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.3.3.1        Mexico: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.3.3.2        Mexico: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.3.4          Mexico: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

10.        North America Colorectal Cancer Diagnostics Market–Industry Landscape

10.1      Overview

10.2      Inorganic Growth Strategies

10.2.1     Overview

10.3      Organic Growth Strategies

10.3.1     Overview

11.        Company Profiles

11.1      Medtronic Plc

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Illumina Inc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Clinical Genomics Technologies Pty Ltd

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      EDP Biotech Corp

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Epigenomics AG

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      F. Hoffmann-La Roche Ltd

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Quest Diagnostics Inc

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Siemens Healthineers AG

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Bruker Corp

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Eiken Chemical Co., Ltd.

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             North America Colorectal Cancer Diagnostics Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Recent Inorganic Growth Strategies in the North America colorectal cancer diagnostics market

Table 15.          Recent Organic Growth Strategies in the North America colorectal cancer diagnostics market

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Colorectal Cancer Diagnostics Market Segmentation

Figure 2.           North America Colorectal Cancer Diagnostics Market, by Country

Figure 3.           North America Colorectal Cancer Diagnostics Market Overview

Figure 4.           Imaging Tests Segment Held Largest Share of Modality Segment in North America Colorectal Cancer Diagnostics Market

Figure 5.           US Expected to Show Remarkable Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           North America Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 9.           North America Colorectal Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)

Figure 11.        Stool Based Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Faecal Immunochemical Test (FIT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Guaiac-based Faecal Occult Blood Test (gFOBT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Stool DNA Test: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Imaging Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Colonoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        CT Colonography: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Flexible Sigmoidoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Capsule Endoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)

Figure 22.        Hospitals: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Laboratories: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Cancer Research Institutes: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27.        North America: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 28.        US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - North America Colorectal Cancer Diagnostics Market

  1. Bruker Corp                                             
  2. Clinical Genomics Technologies Pty Ltd  
  3. EDP Biotech Corp                                         
  4. Eiken Chemical Co., Ltd.                       
  5. Epigenomics AG                                       
  6. F. Hoffmann-La Roche Ltd                   
  7. Illumina Inc        
  8. Medtronic Plc    
  9. Quest Diagnostics Inc                           
  10. Siemens Healthineers AG